Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cerilliant
McKinsey
Federal Trade Commission
Baxter
Chubb
Fuji
AstraZeneca
Harvard Business School

Generated: April 20, 2018

DrugPatentWatch Database Preview

Nucleoside Analog Antiviral Drug Class List

« Back to Dashboard

Drugs in Drug Class: Nucleoside Analog Antiviral

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo CYTOVENE ganciclovir sodium INJECTABLE;INJECTION 019661-001 Jun 23, 1989 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products GANCICLOVIR ganciclovir sodium INJECTABLE;INJECTION 204950-001 Dec 6, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd GANCICLOVIR ganciclovir CAPSULE;ORAL 076457-001 Jun 27, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy Labs Ltd GANCICLOVIR ganciclovir CAPSULE;ORAL 076457-002 Jun 27, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Julphar
McKesson
Chubb
Argus Health
McKinsey
Accenture
Queensland Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.